Tirzepatide was on the FDA’s drug shortage ... and they have customers that maybe have been getting it from the compounding ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

chief advocacy officer for trade group Alliance for Pharmacy Compounding. But the group's members are still reporting that "there's a real lack of availability" of tirzepatide, she said.

Compounding facility ProRx Pharmacy Network has received an FDA warning letter over issues with its semaglutide and ...

Lawyers for the Alliance for Pharmacy Compounding recently sent this letter to the FDA opposing Eli Lilly’s nomination of tirzepatide to the agency’s list of “Drug Products that Present ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

In its petition, Novo Nordisk says that the Outsourcing Facilities Association (OFA), a trade organisation representing the compounding pharmacy ... making copies of tirzepatide, its GLP-1 and ...

The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...

which sued the agency claiming that tirzepatide was still in short supply. As long as the drug shortage was declared, compounding pharmacies were still eligible to produce their own versions of ...

Tirzepatide, however ... the chief advocacy officer at the Alliance for Pharmacy Compounding. For patients with a severe fear of needles or allergies to inactive ingredients in injectable ...

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more ...